Ozagrel

Ozagrel

SCHEMBL28049244

O=C(O)/C=C/c1ccc(Cn2ccnc2)cc1.[NaH].[NaH]

nearest known ligand 0.97

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

TBXAS1

The experimentally established mechanism targets of Ozagrel. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
TBXAS1 known ✓ P24557 14/20 0.97
CYP1A2 P05177 2/20 0.97
USP2 O75604 1/20 0.97
LMNA P02545 1/20 0.97
MEN1 O00255 1/20 0.97
CYP3A4 P08684 1/20 0.97
CYP2D6 P10635 1/20 0.97
CYP2C19 P33261 1/20 0.97
KMT2A Q03164 1/20 0.97
CYP19A1 P11511 1/20 0.57
CYP11B1 P15538 1/20 0.55
CYP11B2 P19099 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ozagrel SCHEMBL582828 1.00 TBXAS1 (0.97) TBXAS1CYP1A2USP2LMNAMEN1
Ozagrel SCHEMBL582827 1.00 TBXAS1 (0.97) TBXAS1CYP1A2USP2LMNAMEN1
Ozagrel SCHEMBL27808192 0.99 TBXAS1 (0.97) TBXAS1CYP1A2USP2LMNAMEN1
Ozagrel SCHEMBL4210 0.99 TBXAS1 (1.00) TBXAS1CYP1A2USP2LMNAMEN1
Ozagrel SCHEMBL4211 0.99 TBXAS1 (1.00) TBXAS1CYP1A2USP2LMNAMEN1
Ozagrel SCHEMBL1652693 0.97 TBXAS1 (0.97) TBXAS1CYP1A2USP2LMNAMEN1
Ozagrel SCHEMBL36182 0.97 TBXAS1 (1.00) TBXAS1CYP1A2USP2LMNAMEN1
Ozagrel SCHEMBL36183 0.97 TBXAS1 (1.00) TBXAS1CYP1A2USP2LMNAMEN1
Ozagrel SCHEMBL10493936 0.96 TBXAS1 (0.97) TBXAS1CYP1A2USP2LMNAMEN1
Ozagrel SCHEMBL10493930 0.96 TBXAS1 (0.97) TBXAS1CYP1A2USP2LMNAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113493416-A (E) Preparation method of (E) -4- (imidazolylmethyl) cinnamate 赤峰经方医药技术开发有限责任公司 2021-10-12 CN disclosed
CN-108026088-A Oxadiazole derivatives as HDAC inhibitors 武田药品工业株式会社 2018-05-11 CN disclosed
CN-105267162-A Injection ozagrel sodium freeze-dried powder for treating cerebral infarction NANJING DUOBAO BIOLOG SCIENCE & TECHNOLOGY CO LTD 2016-01-27 CN disclosed